Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label, Single-arm, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Efficacy of MTM-H-001 in the Treatment of Adult Participants With Relapsed or Refractory B-cell Malignancies (Archonc-001)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07476378
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:12.760344+00:00
Published At
2026-03-17T00:00:00+00:00
Record Updated At
2026-03-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lymphoma, Large B-Cell, Diffuse (DLBCL)", "Lymphoma, Follicular", "Lymphoma, Mantle-Cell", "Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)", "Lymphoma, B-Cell, Marginal Zone", "Transformed Follicular Lymphoma (TFL)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-17"
protocolSection.identificationModule.nctId
"NCT07476378"
protocolSection.identificationModule.officialTitle
"An Open-label, Single-arm, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Efficacy of MTM-H-001 in the Treatment of Adult Participants With Relapsed or Refractory B-cell Malignancies (Archonc-001)"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Lymphoma, Large B-Cell, Diffuse (DLBCL) (protocolSection.conditionsModule.conditions)
  • Lymphoma, Follicular (protocolSection.conditionsModule.conditions)
  • Lymphoma, Mantle-Cell (protocolSection.conditionsModule.conditions)
  • Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (protocolSection.conditionsModule.conditions)
  • Lymphoma, B-Cell, Marginal Zone (protocolSection.conditionsModule.conditions)
  • Transformed Follicular Lymphoma (TFL) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.